CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase
- 25 October 2017
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 34 (4) , 597-605
Abstract
End-stage phase of hypertrophic cardiomyopathy (ES-HCM) is a recognized part of HCM disease spectrum. Information on cardiac magnetic resonance (CMR) studies for ES-HCM especially for those without ventricular remodeling has been limited. We aimed to evaluate the morpho-functional and tissue features of ES-HCM with or without ventricular remodeling and to explore CMR prognostic value in these patients. We analysed CMR scans of sixty-three ES-HCM patients and divided them into those with ventricular dilatation (D-ES, n = 41) and those with normal ventricular size (N-ES, n = 22). Cox proportional hazards models were used to assess the association between CMR parameters and outcomes. Patients in D-ES showed hypokinetic-dilated HCM phenotype, while patients in N-ES showed hypokinetic-restrictive HCM phenotype. LGE extent was significantly larger in D-ES (34.7% ± 15.4% vs. 22.8% ± 7.7%; P < 0.01). Atrial fibrillation and edema of lower extremity were more common in N-ES (72.7 vs. 29.3% and 54.5 vs. 24.4%, respectively; P < 0.05). Log-rank test found no significant difference between 2 groups in combined end point of cardiovascular events (χ2 = 0.66, P = 0.418). In multivariate analysis, LGE (HR 1.57–1.83 per 10% LGE increase, P < 0.01) and indexed left atrial volume (LAVI) (HR 1.14–1.21 per 20 mL/m2 increase, P < 0.05) remained independently associated with combined end point when adjusted by other risk factors. The CMR features of HCM in end-stage span between two extremes. LGE is more extensive in those with ventricular remodeling and LAVI is larger in those with normal ventricular size. Both LGE and LAVI are significant predictors of poor outcomes.Keywords
Funding Information
- Major international (regional) joint research project of National Science Foundation of China (No. 81620108015)
- Capital Characteristic and Clinical Application Research Fund from the Beijing Municipal Commission of Science and Technology (No. Z161100000516110)
This publication has 35 references indexed in Scilit:
- Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post ProcessingJournal of Cardiovascular Magnetic Resonance, 2013
- Risk of Sudden Death in End-Stage Hypertrophic CardiomyopathyJournal of Cardiac Failure, 2011
- Clinical Features of the Dilated Phase of Hypertrophic Cardiomyopathy in Comparison With Those of Dilated CardiomyopathyClinical Cardiology, 2010
- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic ResonanceJACC, 2010
- Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic CardiomyopathyCirculation: Heart Failure, 2010
- Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2009
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- EditorialThe American Journal of Cardiology, 1998
- Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient PopulationNew England Journal of Medicine, 1989
- Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy.Japanese Heart Journal, 1984